Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Spruce Biosciences (SPRB) Total Debt (2022 - 2025)

Spruce Biosciences (SPRB) has disclosed Total Debt for 4 consecutive years, with $539000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Total Debt fell 74.88% to $539000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $539000.0, a 74.88% decrease, with the full-year FY2024 number at $1.7 million, down 47.71% from a year prior.
  • Total Debt was $539000.0 for Q3 2025 at Spruce Biosciences, down from $943000.0 in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $4.9 million in Q4 2022 to a low of $539000.0 in Q3 2025.
  • A 4-year average of $3.2 million and a median of $3.3 million in 2023 define the central range for Total Debt.
  • Peak YoY movement for Total Debt: dropped 7.51% in 2023, then tumbled 74.88% in 2025.
  • Spruce Biosciences' Total Debt stood at $4.9 million in 2022, then tumbled by 32.07% to $3.3 million in 2023, then crashed by 47.71% to $1.7 million in 2024, then plummeted by 69.13% to $539000.0 in 2025.
  • Per Business Quant, the three most recent readings for SPRB's Total Debt are $539000.0 (Q3 2025), $943000.0 (Q2 2025), and $1.3 million (Q1 2025).